MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.
You can purchase shares of MiNK Therapeutics (NASDAQ:INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS), Burning Rock Biotech (NASDAQ:BNR) and Aligos Therapeutics (NASDAQ:ALGS).
MiNK Therapeutics has a consensus price target of $12.00.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $0.7126 last updated October 31, 2024 at 10:03 AM EDT.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.